Clinical Trial Update: Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating extended-release naltrexone for treating heroin dependence in individuals re-entering the jail system has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence
• Opioid-related Disorders

Drugs mentioned

• extended-release naltrexone (naltrexone)

Snippet

Sponsor: NYU Langone Health | Conditions: Heroin Dependence, Opioid-Related Disorders | Phase 4 | Status: COMPLETED | Results posted: 2020-05-27